Cover Image
市場調查報告書

全球癌症診斷市場:趨勢、機會、預測

Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts 2016-2021

出版商 Azoth Analytics 商品編碼 363401
出版日期 內容資訊 英文 132 Pages
訂單完成後即時交付
價格
Back to Top
全球癌症診斷市場:趨勢、機會、預測 Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts 2016-2021
出版日期: 2016年07月15日 內容資訊: 英文 132 Pages
簡介

全球癌症診斷市場預計2016年∼2021年以8.8%的年複合成長率成長。

本報告提供全球癌症診斷市場相關調查分析,各市場區隔的實際成果與未來預測,加上各地區分析,市場動態,政策、規定形勢,SWOT分析,競爭情形等系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 策略性建議

第4章 全球癌症診斷市場:概要

  • 產品概要
  • 影像檢查
  • 內視鏡
  • 切片檢查
  • 腫瘤標記(癌症篩檢)

第5章 北美的癌症診斷市場:概要

  • 市場
  • 各國概要

第6章 亞太地區的癌症診斷市場:概要

  • 各類型,各金額
  • 市場
  • 市場規模:各國

第7章 歐洲的癌症診斷市場:概要

  • 市場
  • 各國概要

第8章 南美的癌症診斷市場:概要

  • 市場
  • 各國概要

第9章 中東、非洲的癌症診斷市場:概要

  • 市場
  • 各國概要

第10章 市場動態

  • 市場趨勢與發展
  • 推動市場要素
  • 課題

第11章 政策法規

第12章 SWOT分析

第13章 五力分析模型

第14章 企業簡介

  • Abbott Laboratories
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche AG (Roche Diagnostics)
  • General Electric Co (General Healthcare)
  • Thermo Fisher Scientific
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Hologic Inc.
  • C. R. Bard Inc.

第15章 關於Azoth Analytics

目錄

Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market

Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve higher growth.

Given the growing demand for early detection of cancer, tumor marker tests are gaining prominence and are projected to witness stronger growth in the coming years.

Growth in the incidences of cancer across the globe is due to the sedentary lifestyle such as increasing tobacco consumption and unhealthy eating habits.

Advancement in genomics has resulted in the growing cancer research, due to which early detection of cancer is gaining popularity.

Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016 - 2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research

North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by countries such as India and China.

According to Azoth Analytics research report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been segmented by type (By Type: Imaging Tests, Endoscopy, Biopsy and Tumor Marker, By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography, By Region: North America, Latin America, APAC, Europe and MEA.)

Scope of the Report

The report provides Segmentation by Type

  • Imaging Tests
  • Endoscopy
  • Biopsy
  • Tumor Marker

The report provides Segmentation by Sub- Type

  • Imaging Tests : MRI, Ultrasound, PET-CT Scan, Mammography

The report provides coverage by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

  • 3.1. North America and Europe to drive the Cancer Diagnostic Market
  • 3.2. Lung, Breast, Bowel and Prostrate Cancers to remain the major cause of Cancer Diagnostics
  • 3.3. Cancer Imaging Test would form the largest market segment for Cancer Diagnosis

4. Global Cancer Diagnostics Market: An Overview

  • 4.1. Product Overview
    • 4.1.1.Global Cancer Diagnostics Market, By Value 2011-2015
    • 4.1.2.Global Cancer Diagnostics Market, By Value 2016-2021F
      • Global Cancer Diagnostics Market: By Type (Imaging Tests, Endoscopy, Biopsy, Tumour Marker Tests)
  • 4.1. Global Imaging Tests Market
    • 4.1.1.By Value (Historic 2011-15)
    • 4.1.2.By Value (Forecast 2016E-2021F)
    • 4.1.3.By Sub-Type - Ultrasound, PET-CT Scan, Mammography, MRI (By Value 2016E-2021F)
  • 4.2. Global Endoscopy Cancer Diagnostics Market
    • 4.2.1.By Value (Historic 2011-15)
    • 4.2.2.By Value (Forecast 2016E-2021F)
  • 4.3. Global Biopsy Market
    • 4.3.1.By Value (Historic 2011-15)
    • 4.3.2.By Value (Forecast 2016E-2021F)
  • 4.4. Global Tumour Marker Tests Market
    • 4.4.1.By Value (Historic 2011-15)
    • 4.4.2.By Value (Forecast 2016E-2021F)
  • 4.5. Global Imaging Test Market, By Region, By Value (2016E-2021F)

5. North America Cancer Diagnostics Market: An Overview

  • 5.1. North America Cancer Diagnostics Market
    • 5.1.1.By Value (Historic 2011-15)
    • 5.1.2.By Value (Forecast 2016E-2021F)
  • 5.2. North America Cancer Diagnostics Country Overview - USA, Canada

6. APAC Cancer Diagnostics Market: An Overview

  • 6.1. APAC Cancer Diagnostics Market
    • 6.1.1.By Value (Historic 2011-15)
    • 6.1.2.By Value (Forecast 2016E-2021F)
  • 6.2. APAC Cancer Diagnostics Country Overview - India, China

7. Europe Cancer Diagnostics Market: An Overview

  • 7.1. Europe Cancer Diagnostics Market
    • 7.1.1.By Value (Historic 2011-15)
    • 7.1.2.By Value (Forecast 2016E-2021F)
  • 7.2. Europe Cancer Diagnostics Country Overview -Denmark, UK

8. Latin America Cancer Diagnostics Market: An Overview

  • 8.1. Latin America Cancer Diagnostics Market
    • 8.1.1.By Value (Historic 2011-15)
    • 8.1.2.By Value (Forecast 2016E-2021F)
  • 8.2. Latin America Cancer Diagnostics Country Overview - Chile, Brazil

9. MEA Cancer Diagnostics Market: An Overview

  • 9.1. MEA Cancer Diagnostics Market
    • 9.1.1.By Value (Historic 2011-15)
    • 9.1.2.By Value (Forecast 2016E-2021F)
  • 9.2. MEA Cancer Diagnostics Country Overview - UAE

10. Market Dynamics

  • 10.1. Market Trends & Developments
  • 10.2. Market Drivers
  • 10.3. Challenges

11. Policy Regulations

12. SWOT Analysis

13. Porter Five Force Model

14. Company Profiling

  • 14.1. Abbott Laboratories
  • 14.2. Becton Dickinson and Company
  • 14.3. F. Hoffmann-La Roche AG (Roche Diagnostics)
  • 14.4. General Electric Co (General Healthcare)
  • 14.5. Thermo Fisher Scientific
  • 14.6. Agilent Technologies, Inc.
  • 14.7. Illumina, Inc.
  • 14.8. Hologic Inc.
  • 14.9. C. R. Bard Inc.

15 About us & Disclaimer

  • Figure 1: Global Cancer Diagnostics Market, 2011-2015 (USD Billion)
  • Figure 2: Global Population Above 65 Percentage of Total Population
  • Figure 3: Major Cancer Among Women
  • Figure 4: Major Cancer Among Men
  • Figure 5: Estimated Cancer Incidences (approx.14 million) in 2012 with Regional Breakup
  • Figure 6: Estimated Cancer Mortality (approx. 8 million) in 2012 with Regional Breakup
  • Figure 7: Global Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
  • Figure 8: Global Population Above 65 (in Million)
  • Figure 9: Global Cancer Diagnostic Imaging Test Market, By Value, 2011-2021F (in USD Billion)
  • Figure 10: Global Imaging Test Market, By Sub-Type, By Value, 2016E (In Percentage)
  • Figure 11: Global Imaging Test Market, By Sub-Type, By Value, 2021F (In Percentage)
  • Figure 12: Ultrasound Cancer Diagnostics Market, By Value, 2011-2021F (in USD Million)
  • Figure 13: PET-CT Scan Market, By Value, 2011-2021F (in USD Million)
  • Figure 14: Global Mammography Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
  • Figure 15: MRI Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
  • Figure 16: Endoscopy Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
  • Figure 17: Biopsy Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
  • Figure 18: Tumour Marker Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
  • Figure 19: Global Imaging Test Market, By Region, By Value, 2016E (In Percentage)
  • Figure 20: Global Imaging Test Market, By Region, By Value2021F (In Percentage)
  • Figure 21: North America Cancer Diagnostics Market, 2011-2015 (USD Billion)
  • Figure 22: North America Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
  • Figure 23: North America Population Above 65 as Percentage of Total Population
  • Figure 24: APAC Cancer Diagnostics Market , 2011-2015 (USD Billion)
  • Figure 25: South Asia Cancer Cases Within Major Countries, 2012
  • Figure 26: Aging Population in South, East Asia and Pacific (in Percentage)
  • Figure 27: APAC Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
  • Figure 28: APAC Population Above 65 as Percentage of Total Population
  • Figure 29: Europe Cancer Diagnostics Market, 2011-2015 (USD Billion)
  • Figure 30: Cancer Survival Rates in Europe in 2012 (in Percentage)
  • Figure 31: Population Above 65 in European Union Region To Total Population (In Percentage)
  • Figure 32: Europe Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
  • Figure 33: Europe Population Above 65 as Percentage of Total Population
  • Figure 34: Latin America Cancer Diagnostics Market, 2011-2015 (USD Million)
  • Figure 35: Aging Population in Latin America (in Percentage)
  • Figure 36: Latin America Cancer Diagnostics Market Size, 2016E-2021F (USD Million)
  • Figure 37: Latin America and Caribbean Population Above 65 as Percentage of Total Population
  • Figure 38: MEA Cancer Diagnostics Market, 2011-2015 (USD Million)
  • Figure 39: Estimated Incidences of Cancer in Africa Per 100,000 (Excluding non-melanoma skin cancer)
  • Figure 40: MEA Cancer Diagnostics Market Size, 2016E-2021F (USD Million)
  • Figure 41: MEA Population Above 65 as Percentage of Total Population
  • Figure 42: Incidences of Cancer Globally
  • Figure 43: Age Group Wise Annual Cases of Cancer between 2009-13 (in Percentage)
  • Figure 44: Population Above 60 Percentage of the total Population Over the Years
  • Figure 45: Region Wise and Segment Wise Breakup for GE
Back to Top